Biodesix, Inc. (BDSX)
14.17
-0.59
(-4.00%)
USD |
NASDAQ |
May 15, 16:00
14.14
-0.03
(-0.21%)
After-Hours: 20:00
Biodesix Shareholders Equity (Quarterly) : 9.132M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Interpace Biosciences, Inc. | 23.08M |
| GRAIL, Inc. | 2.501B |
| FONAR Corp. | 178.57M |
| Thermo Fisher Scientific, Inc. | 51.93B |
| Innovative MedTech, Inc. | -1.053M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.64M |
| Total Liabilities (Quarterly) | 85.50M |
| Debt to Equity Ratio | 7.842 |
| Current Ratio | 2.824 |
| Net Debt Paydown Yield | -1.67% |